ACE Clinical Guidances (ACGs)

ACGs* provide concise, evidence-based recommendations to inform specific areas of clinical practice and serve as a common starting point nationally for clinical decision-making. ACGs are underpinned by a wide array of considerations contextualised to Singapore, based on best available evidence at the time of development. Each ACG is developed in collaboration with a multidisciplinary group of local experts representing relevant specialties and practice settings. ACGs are not exhaustive of the subject matter and do not replace clinical judgement.

Registered doctors, pharmacists and nurses may claim 1 Continuing Medical Education (CME)/Continuing Professional Education (CPE) point under category 3A/ Category V-B for reading each ACG.

*previously known as Appropriate Care Guides

Published on 07 Nov 2018
Last Updated on 07 Nov 2018

A- A+

This Appropriate Care Guide (ACG) highlights the importance of early identification of patients at risk of osteoporosis or fragility fracture. Guidance is provided on risk assessment, correct diagnosis, and management considerations. It also includes a supplementary guide on treatment options and bisphosphonates treatment monitoring.

Download the PDF below to access the full ACG.
Registered doctors, pharmacists and nurses may claim 1 Continuing Medical Education (CME)/Continuing Professional Education (CPE) point under category 3A/ category V-B for reading each ACG.

Key Messages
1.	Assess osteoporosis risk in post-menopausal women, and men 65 years and older.
2.	Diagnose osteoporosis in patients with a fragility fracture or DXA BMD T-score ≤ -2.5.
3.	Treat patients diagnosed with osteoporosis or patients with osteopaenia and high fracture risk.
4.	Refer selected patient groups to a specialist only when necessary.

Osteoporosis - identification and management in primary care (Nov 2018) Supplementary guide on available treatment options (Nov 2018)

Feedback

Click here to give us feedback on this ACG.